|4Dec 28, 4:05 PM ET

Gutfreund John Peter 4

4 · Oncocyte Corp · Filed Dec 28, 2022

Insider Transaction Report

Form 4
Period: 2022-12-23
Transactions
  • Purchase

    Common Stock, no par value

    2022-12-23$0.33/sh+75,000$24,72875,000 total(indirect: see footnote)
Footnotes (2)
  • [F1]The price of $0.3297 per share represents a weighted average of prices ranging from $0.31 to $0.33 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]The shares of common stock are held by Newtown Road 130 Holdings LLC. The Reporting Person is the Managing Member of Newtown Road 130 Holdings LLC and in such capacity has the right to vote and dispose of the securities held by such entity.

Documents

1 file
  • 4
    ownership.xmlPrimary